{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:28:58Z","timestamp":1794022138118,"version":"4.8.0"},"reference-count":99,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Evans\u2019 syndrome (ES) is defined as the concomitant or sequential association of warm auto-immune haemolytic anaemia (AIHA) with immune thrombocytopenia (ITP), and less frequently autoimmune neutropenia. ES is a rare situation that represents up to 7% of AIHA and around 2% of ITP. When AIHA and ITP occurred concomitantly, the diagnosis procedure must rule out differential diagnoses such as thrombotic microangiopathies, anaemia due to bleedings complicating ITP, vitamin deficiencies, myelodysplastic syndromes, paroxysmal nocturnal haemoglobinuria, or specific conditions like HELLP when occurring during pregnancy. As for isolated auto-immune cytopenia (AIC), the determination of the primary or secondary nature of ES is important. Indeed, the association of ES with other diseases such as haematological malignancies, systemic lupus erythematosus, infections, or primary immune deficiencies can interfere with its management or alter its prognosis. Due to the rarity of the disease, the treatment of ES is mostly extrapolated from what is recommended for isolated AIC and mostly relies on corticosteroids, rituximab, splenectomy, and supportive therapies. The place for thrombopoietin receptor agonists, erythropoietin, immunosuppressants, haematopoietic cell transplantation, and thromboprophylaxis is also discussed in this review. Despite continuous progress in the management of AIC and a gradual increase in ES survival, the mortality due to ES remains higher than the ones of isolated AIC, supporting the need for an improvement in ES management.<\/jats:p>","DOI":"10.3390\/jcm9123851","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T09:16:49Z","timestamp":1606468609000},"page":"3851","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["Evans\u2019 Syndrome: From Diagnosis to Treatment"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1772-1392","authenticated-orcid":false,"given":"Sylvain","family":"Audia","sequence":"first","affiliation":[{"name":"Service de M\u00e9decine Interne et Immunologie Clinique, Centre de R\u00e9f\u00e9rence Constitutif des Cytop\u00e9nies Auto-Immunes de l\u2019Adulte, Centre Hospitalo-Universitaire Dijon Bourgogne, Universit\u00e9 de Bourgogne Franche Comt\u00e9, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Grienay","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne et Immunologie Clinique, Centre de R\u00e9f\u00e9rence Constitutif des Cytop\u00e9nies Auto-Immunes de l\u2019Adulte, Centre Hospitalo-Universitaire Dijon Bourgogne, Universit\u00e9 de Bourgogne Franche Comt\u00e9, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Mounier","sequence":"additional","affiliation":[{"name":"Registre des H\u00e9mopathies Malignes de C\u00f4te d\u2019Or, Centre Hospitalo-Universitaire Dijon Bourgogne, Universit\u00e9 de Bourgogne Franche Comt\u00e9, UMR 1231 Dijon, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Michel","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne 1, Centre de R\u00e9f\u00e9rence des Cytop\u00e9nies Auto-Immunes de l\u2019Adulte, Centre Hospitalo-Universitaire Henri Mondor, 94000 Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Bonnotte","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne et Immunologie Clinique, Centre de R\u00e9f\u00e9rence Constitutif des Cytop\u00e9nies Auto-Immunes de l\u2019Adulte, Centre Hospitalo-Universitaire Dijon Bourgogne, Universit\u00e9 de Bourgogne Franche Comt\u00e9, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archinte.1951.03810010058005","article-title":"Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology","volume":"87","author":"Evans","year":"1951","journal-title":"AMA Arch. Intern. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/10245330701521481","article-title":"IgA anti-red blood cell auto-antibodies in Evans syndrome","volume":"12","author":"Moncharmont","year":"2007","journal-title":"Hematology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood-2009-04-215368","article-title":"The spectrum of Evans syndrome in adults: New insight into the disease based on the analysis of 68 cases","volume":"114","author":"Michel","year":"2009","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/ajh.25574","article-title":"Evans syndrome in adults\u2014Incidence, prevalence, and survival in a nationwide cohort","volume":"94","author":"Hansen","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.revmed.2007.08.014","article-title":"Warm autoimmune hemolytic anemias and Evans syndrome in adults","volume":"29","author":"Michel","year":"2008","journal-title":"Rev. Med. Interne"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1182\/blood-2014-06-583021","article-title":"Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: A GIMEMA study of 308 patients","volume":"124","author":"Barcellini","year":"2014","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Jager, U., Barcellini, W., Broome, C.M., Gertz, M.A., Hill, A., Hill, Q.A., Jilma, B., Kuter, D.J., Michel, M., and Montillo, M. (2019). Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev.","DOI":"10.1016\/j.blre.2019.100648"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/bjh.15404","article-title":"Detection of platelet autoantibodies to identify immune thrombocytopenia: State of the art","volume":"182","author":"Porcelijn","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/asheducation-2016.1.38","article-title":"Autoimmune and other acquired neutropenias","volume":"2016","author":"Newburger","year":"2016","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1525-1438.2002.00053.x","article-title":"Report on the Fourth International Granulocyte Immunology Workshop: Progress toward quality assessment","volume":"42","author":"Lucas","year":"2002","journal-title":"Transfusion"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.autrev.2014.01.001","article-title":"Diagnostic criteria for autoimmune neutropenia","volume":"13","author":"Youinou","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood-2014-06-583260","article-title":"Autoimmune and other cytopenias in primary immunodeficiencies: Pathomechanisms, novel differential diagnoses, and treatment","volume":"124","author":"Seidel","year":"2014","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3389\/fonc.2019.01435","article-title":"Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects","volume":"9","author":"Fattizzo","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00277-016-2642-x","article-title":"Evans syndrome secondary to chronic lymphocytic leukaemia: Presentation, treatment, and outcome","volume":"95","author":"Carli","year":"2016","journal-title":"Ann. Hematol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e3279","DOI":"10.1097\/MD.0000000000003279","article-title":"Clinical Features of Systemic Lupus Erythematosus Patients Complicated With Evans Syndrome: A Case-Control, Single Center Study","volume":"95","author":"Zhang","year":"2016","journal-title":"Medicine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jbspin.2011.07.004","article-title":"Evans syndrome and systemic lupus erythematosus: Clinical presentation and outcome","volume":"79","author":"Costallat","year":"2012","journal-title":"Jt. Bone Spine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1111\/bjh.16846","article-title":"Evans syndrome in a patient with COVID-19","volume":"190","author":"Li","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e27260","DOI":"10.1002\/pbc.27260","article-title":"Diagnosis and management of chronic and refractory immune cytopenias in children, adolescents, and young adults","volume":"65","author":"Rotz","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2009.11.022","article-title":"Evans\u2019 syndrome in pregnancy: A systematic literature review and two new cases","volume":"149","author":"Lefkou","year":"2010","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/asheducation-2017.1.651","article-title":"Thrombocytopenia in hospitalized patients: Approach to the patient with thrombotic microangiopathy","volume":"2017","author":"Scully","year":"2017","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ajh.24665","article-title":"Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre","volume":"92","author":"Grall","year":"2017","journal-title":"Am. J. Hematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2257.2006.00755.x","article-title":"Current hematological findings in cobalamin deficiency. A study of 201 consecutive patients with documented cobalamin deficiency","volume":"28","author":"Andres","year":"2006","journal-title":"Clin. Lab. Haematol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","article-title":"Paroxysmal nocturnal hemoglobinuria","volume":"124","author":"Brodsky","year":"2014","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2015-07-659656","article-title":"High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: A prospective multicenter randomized trial","volume":"127","author":"Wei","year":"2016","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2352-3026(16)30109-0","article-title":"High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: A systematic review and meta-analysis","volume":"3","author":"Mithoowani","year":"2016","journal-title":"Lancet Haematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ajh.2830440404","article-title":"Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: Results in 73 patients","volume":"44","author":"Flores","year":"1993","journal-title":"Am. J. Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(02)07275-6","article-title":"Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: A randomised, multicentre trial","volume":"359","author":"Godeau","year":"2002","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/bjh.12541","article-title":"A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia","volume":"163","author":"Birgens","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Michel, M., Terriou, L., Roudot-Thoraval, F., Hamidou, M., Ebbo, M., Le Guenno, G., Galicier, L., Audia, S., Royer, B., and Sophie Morin, A. (2016). A Randomized and Double-Blind Controlled Trial Evaluating the Safety and Efficacy of Rituximab for Warm Auto-Immune Hemolytic Anemia in Adults (the RAIHA study). Am. J. Hematol.","DOI":"10.1002\/ajh.24570"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/ajh.25632","article-title":"Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux","volume":"94","author":"Deshayes","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fped.2015.00079","article-title":"Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort","volume":"3","author":"Aladjidi","year":"2015","journal-title":"Front. Pediatr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3324\/haematol.11540","article-title":"Rituximab therapy for childhood Evans syndrome","volume":"92","author":"Aladjidi","year":"2007","journal-title":"Haematologica"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2004-03-1168","article-title":"Splenectomy for adult patients with idiopathic thrombocytopenic purpura: A systematic review to assess long-term platelet count responses, prediction of response, and surgical complications","volume":"104","author":"Kojouri","year":"2004","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"E150","DOI":"10.1002\/ajh.23767","article-title":"Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single-center experience with 60 patients","volume":"89","author":"Roumier","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2141.1990.tb02569.x","article-title":"Re-evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: A report on 53 cases","volume":"74","author":"Quiquandon","year":"1990","journal-title":"Br. J. Haematol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/blood.V64.6.1179.1179","article-title":"Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: Multicentric Trial of the Cooperative Latin American group on Hemostasis and Thrombosis","volume":"64","author":"Pizzuto","year":"1984","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.3324\/haematol.13481","article-title":"Efficacy of cyclosporine as a single agent therapy in chronic idiopathic thrombocytopenic purpura","volume":"93","author":"Choudhary","year":"2008","journal-title":"Haematologica"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1365-2141.2001.02893.x","article-title":"Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy","volume":"114","year":"2001","journal-title":"Br. J. Haematol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/bjh.14261","article-title":"Mycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology\/oncology","volume":"175","author":"Miano","year":"2016","journal-title":"Br. J. Haematol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","article-title":"A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation","volume":"118","author":"Neven","year":"2011","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/bjh.13622","article-title":"Mycophenolate mofetil therapy for severe immune thrombocytopenia","volume":"171","author":"Taylor","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/09537104.2010.520372","article-title":"Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and\/or splenectomy in adults","volume":"22","author":"Colovic","year":"2011","journal-title":"Platelets"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Stirnemann, J., Kaddouri, N., Khellaf, M., Morin, A.S., Prendki, V., Michel, M., Mekinian, A., Bierling, P., Fenaux, P., and Godeau, B. (2015). Vincristine efficacy and safety in treating immune thrombocytopenia: A retrospective study of 35 patients. Eur. J. Haematol.","DOI":"10.1111\/ejh.12586"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.revmed.2015.08.007","article-title":"Is there still a place for \u201cold therapies\u201d in the management of immune thrombocytopenia?","volume":"37","author":"Audia","year":"2016","journal-title":"Rev. Med. Interne"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/jca.20096","article-title":"Plasma exchanges do not increase red blood cell transfusion efficiency in severe autoimmune hemolytic anemia: A retrospective case-control study","volume":"21","author":"Ruivard","year":"2006","journal-title":"J. Clin. Apher."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1526-0968.2003.00004.x","article-title":"Plasmapheresis in immune hematology: Review of clinical outcome data with respect to evidence-based medicine and clinical experience","volume":"7","year":"2003","journal-title":"Ther Apher. Dial."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice\u2014Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J. Clin. Apher."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bjh.14478","article-title":"The diagnosis and management of primary autoimmune haemolytic anaemia","volume":"176","author":"Hill","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/trf.15069","article-title":"Platelet transfusion practices in immune thrombocytopenia related hospitalizations","volume":"59","author":"Goel","year":"2019","journal-title":"Transfusion"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ajh.21060","article-title":"Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: A retrospective review of 40 patients","volume":"83","author":"Spahr","year":"2008","journal-title":"Am. J. Hematol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Audia, S., Bach, B., Samson, M., Lakomy, D., Bour, J.B., Burlet, B., Guy, J., Duvillard, L., Branger, M., and Leguy-Seguin, V. (2018). Venous thromboembolic events during warm autoimmune hemolytic anemia. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0207218"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/1024533021000059474","article-title":"Auto-immune haemolytic anaemia--a high-risk disorder for thromboembolism?","volume":"8","author":"Hendrick","year":"2003","journal-title":"Hematology"},{"key":"ref_56","first-page":"232","article-title":"Hemolytic disorders and venous thrombosis: An update","volume":"40","author":"Graveleau","year":"2019","journal-title":"Rev. Med. Interne"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.thromres.2014.10.012","article-title":"Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: A study among a U.S. cohort of commercial insurance enrollees","volume":"135","author":"Yusuf","year":"2015","journal-title":"Thromb. Res."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Fattizzo, B., Michel, M., Zaninoni, A., Giannotta, J., Guillet, S., Frederiksen, H., Vos, J.M.I., Mauro, F.R., Jilma, B., and Patriarca, A. (2020). Efficacy of recombinant erythropoietin in autoimmune haemolytic anaemia: A multicentre international study. Haematologica.","DOI":"10.3324\/haematol.2020.250522"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa073275","article-title":"Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura","volume":"357","author":"Bussel","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(08)60203-2","article-title":"Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: A double-blind randomised controlled trial","volume":"371","author":"Kuter","year":"2008","journal-title":"Lancet"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/0961203311404913","article-title":"The efficacy of romiplostim in the treatment of severe thrombocytopenia associated to Evans syndrome refractory to rituximab","volume":"20","author":"Quattrino","year":"2011","journal-title":"Lupus"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1179\/1607845412Y.0000000060","article-title":"Simultaneous romiplostin, eltrombopag, and prednisone were successful in severe thrombocytopenia of Evans syndrome refractory to hydrocortisone, splenectomy, intravenous IgG, and rituximab","volume":"18","year":"2013","journal-title":"Hematology"},{"key":"ref_63","first-page":"829","article-title":"Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count","volume":"90","author":"Khellaf","year":"2005","journal-title":"Haematologica"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00062752-200311000-00006","article-title":"Red blood cell transfusion in autoimmune hemolytic anemia","volume":"10","author":"Buetens","year":"2003","journal-title":"Curr. Opin. Hematol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ajh.24999","article-title":"Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults","volume":"93","author":"Serris","year":"2018","journal-title":"Am. J. Hematol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/ejh.13336","article-title":"Long-term remission rates after splenectomy in adults with Evans syndrome compared to immune thrombocytopenia: A single-center retrospective study","volume":"104","author":"Sulpizio","year":"2020","journal-title":"Eur. J. Haematol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2015-07-657981","article-title":"Sirolimus is effective in relapsed\/refractory autoimmune cytopenias: Results of a prospective multi-institutional trial","volume":"127","author":"Bride","year":"2016","journal-title":"Blood"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3389\/fimmu.2020.00946","article-title":"The Changing Landscape of Autoimmune Hemolytic Anemia","volume":"11","author":"Barcellini","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_69","unstructured":"Audia, S., Mahevas, M., and Bonnotte, B. (2020). Immune thrombocytopenia: From pathogenesis to treatment. Rev. Med. Interne."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2001-12-0171","article-title":"High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia","volume":"101","author":"Huhn","year":"2003","journal-title":"Blood"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1080\/08916930802198436","article-title":"Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias","volume":"41","author":"Passweg","year":"2008","journal-title":"Autoimmunity"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Moulis, G., Comont, T., and Adoue, D. (2020). New insights into the epidemiology of immune thrombocytopenia in adult patients: Impact for clinical practice. Rev. Med. Interne.","DOI":"10.1016\/j.revmed.2020.05.018"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.autrev.2015.07.001","article-title":"Venous thromboembolism related to warm autoimmune hemolytic anemia: A case-control study","volume":"14","author":"Neel","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Michel, M., Ruggeri, M., Gonzalez-Lopez, T.J., Alkindi, S.S., Cheze, S., Ghanima, W., Tvedt, T.H.A., Ebbo, M., Terriou, L., and Bussel, J.B. (2020). Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: Results from a multicenter study. Blood.","DOI":"10.1182\/blood.2020007594"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/rheumatology\/kes164","article-title":"Modified neonatal B-cell repertoire as a consequence of rituximab administration to a pregnant woman","volume":"52","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1182\/blood-2007-01-065763","article-title":"Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP)","volume":"110","author":"Boruchov","year":"2007","journal-title":"Blood"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Roumier, M., Le Burel, S., Audia, S., Chauchet, A., Goussef, M., Hamidou, M., Liferman, F., Moulis, G., Lioger, B., and Galicier, L. (2020). High dose Romiplostim as a rescue therapy for adults with severe bleeding and refractory immune thrombocytopenia. Am. J. Hematol.","DOI":"10.1002\/ajh.26040"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2141.2004.04841.x","article-title":"A physician\u2019s guide to transfusion in autoimmune haemolytic anaemia","volume":"124","author":"Petz","year":"2004","journal-title":"Br. J. Haematol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/1744666X.2018.1521722","article-title":"Current and emerging treatment options for autoimmune hemolytic anemia","volume":"14","author":"Barcellini","year":"2018","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_80","first-page":"9181698","article-title":"Refractory IgG Warm Autoimmune Hemolytic Anemia Treated with Eculizumab: A Novel Application of Anticomplement Therapy","volume":"2016","author":"Ma","year":"2016","journal-title":"Case Rep. Hematol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Neave, L., Wilson, A.J., Lissack, M., and Scully, M. (2018). Severe refractory idiopathic warm autoimmune haemolytic anaemia responsive to complement inhibition with eculizumab. BMJ Case Rep., 11.","DOI":"10.1136\/bcr-2018-226429"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Mannering, N., Hansen, D.L., and Frederiksen, H. (2020). Evans syndrome in children below 13 years of age\u2014A nationwide population-based cohort study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0231284"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri3850","article-title":"Aicardi-Goutieres syndrome and the type I interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2018-11-887141","article-title":"Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes","volume":"134","author":"Hadjadj","year":"2019","journal-title":"Blood"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","article-title":"Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review","volume":"7","author":"Fabre","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase \u03b4 gene mutation predisposes to respiratory infection and airway damage","volume":"342","author":"Angulo","year":"2013","journal-title":"Science"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Neven, Q., Boulanger, C., Bruwier, A., de Ville de Goyet, M., Meyts, I., Moens, L., Van Damme, A., and Brichard, B. (2020). Clinical Spectrum of Ras-Associated Autoimmune Leukoproliferative Disorder (RALD). J. Clin. Immunol.","DOI":"10.1007\/s10875-020-00883-7"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood-2009-01-198416","article-title":"Mutations in CBL occur frequently in juvenile myelomonocytic leukemia","volume":"114","author":"Loh","year":"2009","journal-title":"Blood"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.jaip.2019.02.038","article-title":"Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency","volume":"7","author":"Farmer","year":"2019","journal-title":"J. Allergy Clin. Immunol Pract."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJMoa073966","article-title":"An immunodeficiency disease with RAG mutations and granulomas","volume":"358","author":"Schuetz","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.2414","article-title":"Mutations in ADAR1 cause Aicardi-Gouti\u00e8res syndrome associated with a type I interferon signature","volume":"44","author":"Rice","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10875-017-0456-9","article-title":"Autoimmune Cytopenias and Associated Conditions in CVID: A Report from the USIDNET Registry","volume":"38","author":"Feuille","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.md.0000133624.65946.40","article-title":"Autoimmune thrombocytopenic purpura and common variable immunodeficiency: Analysis of 21 cases and review of the literature","volume":"83","author":"Michel","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","article-title":"Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): Report from the 2009 NIH International Workshop","volume":"116","author":"Oliveira","year":"2010","journal-title":"Blood"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1182\/blood-2011-07-325217","article-title":"How I treat autoimmune lymphoproliferative syndrome","volume":"118","author":"Rao","year":"2011","journal-title":"Blood"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clim.2017.12.009","article-title":"Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations","volume":"188","author":"Besnard","year":"2018","journal-title":"Clin. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/ACI.0000000000000590","article-title":"Disorders of CTLA-4 expression, how they lead to CVID and dysregulated immune responses","volume":"19","author":"Sun","year":"2019","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/12\/3851\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:38:20Z","timestamp":1760179100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/12\/3851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,27]]},"references-count":99,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["jcm9123851"],"URL":"https:\/\/doi.org\/10.3390\/jcm9123851","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,27]]}}}